key: cord-0910199-mazibibn
authors: Gonzalez, F.; Vielot, N. A.; Sciaudone, M.; Toval-Ruiz, C.; PREMKUMAR, L.; Gutierrez, L.; Centeno Cuadra, E.; Blandon, P.; de Silva, A.; Rubinstein, R.; Bowman, N.; Becker-Dreps, S.; Bucardo, F.
title: Seroepidemiology of SARS-CoV-2 infections in an urban Nicaraguan population
date: 2021-03-01
journal: medRxiv : the preprint server for health sciences
DOI: 10.1101/2021.02.25.21252447
sha: 64bfed18e00caede2e367f2bd37fdb823851b877
doc_id: 910199
cord_uid: mazibibn

In a Nicaraguan population-based cohort, SARS-CoV-2 seroprevalence was 34%, with higher prevalence in children compared to adults. Having a seropositive household member was associated with a two-fold probability of individual seropositivity, suggesting a role for household transmission. Co-morbidities and preventive behaviors were not associated with SARS-CoV-2 seroprevalence.

The Sapovirus-Associated Gastro-Enteritis (SAGE) study is a population-based birth cohort study in 3 0 León, Nicaragua, described previously. 4 This cohort provided a platform to access a sample of all ages to 3 1 understand the seroprevalence of SARS-CoV-2 in a Latin American context, and to examine differences 3 2 in participant characteristics by evidence of prior infection. The study population included high-income 3 3 families in the city center and low-income families in peri-urban neighborhoods, creating a scientifically- 3 4 informative gradient to evaluate socioeconomic and environmental risk factors for SARS-CoV-2 3 5 infection. Starting in July 2020, we contacted the household members of cohort children (both adults and 3 6 children) and offered participation in this study. We also offered participation in the study for cohort 3 7 children, including those who had reached 36 months of age. The study was approved by the Institutional 3 8

Review Boards of the National Autonomous University of Nicaragua, León (UNAN-León, acta No. 170, 3 9 2020) and the University of North Carolina at Chapel Hill (Study #: 20-2126). All adult participants 4 0 provided informed consent, and parental permission was required for children's participation in the study. 4 1 In September and October 2020, we collected baseline demographic and health history data and collected 4 2 blood from all participants for baseline SARS-CoV-2 serology. The current report summarizes the 4 3 seroprevalence of SARS-CoV-2, stratifying by co-morbidities and sociodemographic factors.

Specimen Collection and Laboratory Methods 4 5 SARS-CoV-2 infection induces the production of antibodies (Ab) against the spike protein and 4 6 nucleocapsid protein, with most patients seroconverting within 2 weeks of symptom onset. 5 We used an 4 7 in-house enzyme-linked immunosorbent (ELISA) assay to measure antibodies (IgG, IgA, and IgM) to the 4 8 receptor binding domain (RBD) of the SARS-CoV-2 spike protein, which we have previously shown to 4 9 be highly sensitive and specific for detecting antibodies for at least six months among individuals 5 0 experiencing symptomatic infection. 5 The spike RBD-based assay does not cross-react with common 5 1 endemic coronaviruses, and the magnitude of RDB antibody titers correlate with neutralizing antibody 5 2 titers, currently the best correlate of protection against infection. 5 In brief, ELISA plates (Greiner Bio-One 5 3 #655061) were coated with 4µg/ml of the RBD antigen. Heat-inactivated serum diluted at 1:40 was 5 4 high among individuals who lived with another seropositive household member (PR: 1.97, 95% CI: 1.43, 7 9 2.69). 8 0

Our results show a high rate of seropositivity for SARS-CoV-2 antibodies in a Nicaraguan population-8 2 based cohort. This suggests the actual number of SARS-CoV-2 infections in Nicaragua was higher than 8 3 official reports, which might be explained by a high rate of asymptomatic and mild cases that did not seek 8 4 medical attention, or by limited testing of patients who received medical attention. Our seroprevalence 8 5 results are similar to those of another study from Brazil, 7 and those reported from SARS-CoV-2 hot spots 8 6 in high income countries, such as Massachusetts and Northern Italy, although the Massachusetts study 8 7 was not carried out in a population-based cohort. 2, 8 In these studies, the seroprevalence of SARS-CoV-2 8 8 antibodies was higher than expected based on the reported incidence of symptomatic SARS-CoV-2 8 9

operation of public schools throughout the epidemic. As children are more likely to experience mild 1 0 4 symptoms than adults, 11 this finding suggests that school-aged children may contribute to active 1 0 5 transmission, and controlling infections in this sub-population is essential to reduce the spread of SARS-1 0 6

CoV-2. We also found that most individuals reported practicing strict physical distancing or masking 1 0 7 behavior outside of the home, though this did not have a significant impact on the seroprevalence. 1 0 8

Transmission within the home may have been more important. 12 The median household size in our 1 0 9 sample was 7 members, with a maximum of 26 members. Indeed, SARS-CoV-2 seropositivity was two-1 1 0 fold more frequent for individuals with a seropositive household member as compared to individuals who 1 1 1 did not have a seropositive household member. 1 1 2

In conclusion, we found a high SARS-CoV-2 seroprevalence in this Nicaraguan population and 1 1 3

confirmed that reported SARS-CoV-2 case counts underestimated the true number of infections. We also 1 1 4 show that this population has not yet attained the theoretical community immunity threshold, and so 1 1 5 continued containment measures are necessary. In the future, this population could be followed to 1 1 6 understand the risk of recurrent infection, and repeated seroprevalence measurements could provide 1 1 7 further information on transmission dynamics. 1 1 8

All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 1, 2021.

We greatly appreciate Yorling Picado, Nancy Corea Munguia, Franco Soto, and the SAGE field team for 1 2 0 their important contributions to this study. The authors report no conflicts of interest. 1 2 7

All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Diagnosed by medical professional as reported by participant, including diabetes, hypertension, obesity, malignancy, and autoimmune disease. c Strict = never left the house since first cases reported or occasionally leaves house and always uses a mask; Moderate=Occasionally leaves the house and sometimes uses a mask; None = Occasionally leaves the house and never uses a mask or no distancing or quarantine behavior. d Poverty index calculated based on presence of basic needs, including household sanitation, education, economic dependency, and household crowding.

COVID-19 Map -Johns Hopkins Coronavirus Resource Center

Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the

Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China

Risk Factors and Clinical Profile of Sapovirus-associated

Acute Gastroenteritis in Early Childhood: A Nicaraguan Birth Cohort Study

The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients

Interim Guidelines for COVID-19 Antibody Testing

Population-based seroprevalence of SARS-CoV-2 and the herd immunity threshold in Maranhão

The duration, dynamics and determinants of SARS-CoV-2 antibody responses in individual healthcare workers

First report on prevalence of SARS-CoV-2 infection among health-care workers in Nicaragua

Asymptomatic SARS-CoV-2 Carriers: A Systematic Review and Meta-Analysis. Front Public Health

SARS-CoV-2 transmission in the Lombardy Region: the increase of household contagion and its implication for containment measures

No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity